Celltrion
068270.KS
#859
Rank
A$39.93 B
Marketcap
A$182.98
Share price
2.41%
Change (1 day)
12.27%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.62. an increase over its 2024 EPS that were of A$1.70.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025A$4.49163.66%
2024A$1.70-53.73%
2023A$3.68-2.08%
2022A$3.76-11.72%
2021A$4.262.03%
2020A$4.1782.8%
2019A$2.2818.31%
2018A$1.93-36.33%
2017A$3.03161.25%
2016A$1.162.86%
2015A$1.1317.84%
2014A$0.965.87%
2013A$0.90-70.85%
2012A$3.10134.09%
2011A$1.3343.59%
2010A$0.9274.49%
2009A$0.53317.8%
2008A$0.13-71.7%
2007A$0.45